Overview
The Office of Pharmaceutical Policy and Analysis (OPPA) was established with the goal of conducting nation-leading research and developing key policy recommendations related to pharmaceutical drug access and affordability, serving as the hub of expertise on pharmaceutical drug policy for the Commonwealth.
The main functions of OPPA are to collect and analyze pharmaceutical spending data and information, develop and share reports and cutting-edge analyses of trends related to access, affordability, and spending on pharmaceutical drugs in the Commonwealth, and issue recommendations on pivotal matters related to pharmaceutical policy.
Resources and Related Work
- Establishing Statute: Chapter 342 of the Acts of 2024
- DataPoints Issue #27: Blockbuster GLP-1 Weight-Loss Drugs in Massachusetts, 2024
- Prescription Drug Coupon Study: Report to the Massachusetts Legislature, 2020
- Review of Third-Party Specialty Pharmacy Use for Clinician-Administered Drugs, 2019
- DataPoints Issue #12: Cracking Open the Black Box of Pharmacy Benefit Managers, 2019
- DataPoints Issue #11: Insulin Price Growth and Patient Out-of-Pocket Spending, 2019